Target intelligence / Profile preview

Natriuretic peptide receptor 3 (NPR3) (NPR3)

Target
NPR3
Molecular classification
Receptor, Natriuretic peptide receptor family
01

Overview

The Natriuretic peptide receptor 3 (NPR3), historically identified in guinea pig lung tissue as an NPR-like binding site, is a single-pass transmembrane protein that serves as the primary clearance receptor for natriuretic peptides (PubMed: 2527127). Unlike the signaling receptors NPR1 and NPR2, NPR3 lacks an intracellular guanylyl cyclase domain and instead functions to regulate the circulating levels of atrial, brain, and C-type natriuretic peptides through receptor-mediated endocytosis and subsequent lysosomal degradation (UniProt: P21729). In addition to its clearance role, NPR3 is known to couple with inhibitory G-proteins (Gi) to modulate adenylyl cyclase activity, thereby influencing various intracellular signaling pathways (PubMed: 15837019). In the lung, NPR3 is highly expressed and plays a vital role in maintaining vascular homeostasis and fluid balance by controlling the local availability of natriuretic peptides (PubMed: 2161580). Pharmacological modulation of NPR3 is a therapeutic strategy aimed at increasing the half-life of endogenous natriuretic peptides to treat cardiovascular and pulmonary diseases (PubMed: 11591457).

Other names
Natriuretic peptide receptor CNPR-CAtrial natriuretic peptide receptor type CANP clearance receptorGuinea-pig lung NPR-like siteGUCY2B
02

Mechanism of action

Acts as a clearance receptor by internalizing natriuretic peptides for degradation and inhibits adenylyl cyclase through Gi protein coupling.

03

Biological functions

Peptide clearanceSignal transductionRegulation of vascular toneFluid homeostasisInhibition of adenylyl cyclase
04

Disease associations

HypertensionHeart failureCardiovascular diseasePulmonary hypertensionObesity
05

Safety considerations

HypotensionRenal function alterationsElectrolyte imbalanceSystemic peptide homeostasis disruption
06

Interacting drugs

Atrial natriuretic peptide (ANP)

4 more in the full profile.

07

Biomarkers

Plasma atrial natriuretic peptide (ANP) levelsPlasma brain natriuretic peptide (BNP) levelsCyclic GMP (cGMP) levels (indirectly)

Beyond the preview

Go deeper on Natriuretic peptide receptor 3 (NPR3) (NPR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natriuretic peptide receptor 3 (NPR3) (NPR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call